Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of ADVANCED ENZYME TECHNOLOGIES. For more details, see the ADVANCED ENZYME TECHNOLOGIES quarterly results and ADVANCED ENZYME TECHNOLOGIES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.2 |
No. of shares | m | 111.82 |
1 Week | % | -1.3 |
1 Month | % | -0.3 |
1 Year | % | 40.3 |
52 week H/L | Rs | 425.1/249.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ADVANCED ENZYME TECHNOLOGIES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 263 | 225 | 417 | 503 | 328 | |
Low | Rs | 145 | 91 | 129 | 257 | 225 | |
Sales per share (Unadj.) | Rs | 37.6 | 39.8 | 44.9 | 47.4 | 48.3 | |
Earnings per share (Unadj.) | Rs | 10.4 | 11.9 | 13.5 | 11.1 | 9.3 | |
Diluted earnings per share | Rs | 10.4 | 11.9 | 13.5 | 11.1 | 9.3 | |
Cash flow per share (Unadj.) | Rs | 12.3 | 14.2 | 16.1 | 14.2 | 12.4 | |
Dividends per share (Unadj.) | Rs | 0.60 | 0.60 | 0.90 | 1.00 | 5.00 | |
Adj. dividends per share | Rs | 0.60 | 0.60 | 0.90 | 1.00 | 5.00 | |
Avg Dividend yield | % | 0.3 | 0.4 | 0.3 | 0.3 | 1.8 | |
Book value per share (Unadj.) | Rs | 60.5 | 74.9 | 86.7 | 97.4 | 110.5 | |
Adj. book value per share | Rs | 60.4 | 74.8 | 86.6 | 97.3 | 110.4 | |
Shares outstanding (eoy) | m | 111.65 | 111.68 | 111.73 | 111.73 | 111.82 | |
Price / Sales ratio | x | 5.4 | 4.0 | 6.1 | 8.0 | 5.7 | |
Avg P/E ratio | x | 19.7 | 13.3 | 20.2 | 34.3 | 29.8 | |
P/CF ratio (eoy) | x | 16.7 | 11.1 | 16.9 | 26.7 | 22.3 | |
Price / Book Value ratio | x | 3.4 | 2.1 | 3.1 | 3.9 | 2.5 | |
Dividend payout | % | 5.8 | 5.0 | 6.6 | 9.0 | 53.8 | |
Avg Mkt Cap | Rs m | 22,818 | 17,648 | 30,491 | 42,457 | 30,939 | |
Total wages/salary | Rs m | 780 | 802 | 871 | 1,040 | 1,148 |
ADVANCED ENZYME TECHNOLOGIES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 4,196 | 4,440 | 5,018 | 5,294 | 5,406 | |
Other income | Rs m | 57 | 59 | 88 | 64 | 255 | |
Total revenues | Rs m | 4,253 | 4,499 | 5,107 | 5,358 | 5,661 | |
Gross profit | Rs m | 1,826 | 2,031 | 2,326 | 2,026 | 1,534 | |
Depreciation | Rs m | 211 | 258 | 287 | 350 | 350 | |
Interest | Rs m | 52 | 41 | 26 | 30 | 35 | |
Profit before tax | Rs m | 1,620 | 1,792 | 2,101 | 1,711 | 1,404 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 461 | 461 | 588 | 473 | 365 | |
Profit after tax | Rs m | 1,159 | 1,330 | 1,513 | 1,238 | 1,039 | |
Gross profit margin | % | 43.5 | 45.8 | 46.3 | 38.3 | 28.4 | |
Effective tax rate | % | 28.4 | 25.7 | 28.0 | 27.6 | 26.0 | |
Net profit margin | % | 27.6 | 30.0 | 30.1 | 23.4 | 19.2 |
ADVANCED ENZYME TECHNOLOGIES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 2,821 | 3,756 | 5,160 | 6,044 | 7,221 | |
Current liabilities | Rs m | 651 | 595 | 676 | 604 | 776 | |
Net working cap to sales | % | 51.7 | 71.2 | 89.4 | 102.8 | 119.2 | |
Current ratio | x | 4.3 | 6.3 | 7.6 | 10.0 | 9.3 | |
Inventory Days | Days | 107 | 116 | 102 | 85 | 255 | |
Debtors Days | Days | 51 | 61 | 63 | 61 | 68 | |
Net fixed assets | Rs m | 5,183 | 5,908 | 6,333 | 6,558 | 6,884 | |
Share capital | Rs m | 223 | 223 | 223 | 224 | 224 | |
"Free" reserves | Rs m | 6,530 | 8,137 | 9,460 | 10,656 | 12,127 | |
Net worth | Rs m | 6,753 | 8,360 | 9,683 | 10,880 | 12,351 | |
Long term debt | Rs m | 70 | 42 | 99 | 81 | 78 | |
Total assets | Rs m | 8,052 | 9,712 | 11,493 | 12,602 | 14,105 | |
Interest coverage | x | 32.1 | 44.9 | 82.8 | 58.9 | 41.4 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | |
Return on assets | % | 15.0 | 14.1 | 13.4 | 10.1 | 7.6 | |
Return on equity | % | 17.2 | 15.9 | 15.6 | 11.4 | 8.4 | |
Return on capital | % | 24.5 | 21.8 | 21.7 | 15.9 | 11.6 | |
Exports to sales | % | 15.9 | 16.4 | 12.9 | 13.9 | 17.3 | |
Imports to sales | % | 6.8 | 6.1 | 5.9 | 8.2 | 7.8 | |
Exports (fob) | Rs m | 669 | 729 | 648 | 736 | 937 | |
Imports (cif) | Rs m | 286 | 269 | 298 | 435 | 420 | |
Fx inflow | Rs m | 669 | 729 | 648 | 736 | 937 | |
Fx outflow | Rs m | 286 | 269 | 298 | 435 | 420 | |
Net fx | Rs m | 383 | 459 | 351 | 301 | 518 |
ADVANCED ENZYME TECHNOLOGIES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,286 | 1,409 | 1,630 | 1,223 | 1,404 | |
From Investments | Rs m | -1,247 | -445 | -260 | -38 | -2,982 | |
From Financial Activity | Rs m | -431 | -386 | -264 | -485 | -258 | |
Net Cashflow | Rs m | -381 | 596 | 1,093 | 754 | -1,709 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Vasant Rathi | COMP SEC: Sanjay Basantani | YEAR OF INC: 1989 | BSE CODE: 540025 | FV (Rs): 2 | DIV YIELD (%): 1.4 |
Read: ADVANCED ENZYME TECHNOLOGIES 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ADVANCED ENZYME TECHNOLOGIES With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.